Seroatlas · Human Serome Atlas

HOGA1

4-hydroxy-2-oxoglutarate aldolase, mitochondrial

Also known as: C10orf65, DHDPS2, DHDPSL, FLJ37472, HOGA1_HUMAN, NPL2

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q86XE5
Gene
HOGA1
Ensembl
ENSG00000241935
Chromosome
10
Canonical length
327 aa
Protein class
Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
Quaternary structure
Homotetramer

OverviewNCBI Gene

The authors of PMID:20797690 cloned this gene while searching for genes in a region of chromosome 10 linked to primary hyperoxalurea type III. They noted that even though the encoded protein has been described as a mitochondrial dihydrodipicolinate synthase-like enzyme, it shares little homology with E. coli dihydrodipicolinate synthase (Dhdps), particularly in the putative substrate-binding region. Moreover, neither lysine biosynthesis nor sialic acid metabolism, for which Dhdps is responsible, occurs in vertebrate mitochondria. They propose that this gene encodes mitochondrial 4-hydroxyl-2-oxoglutarate aldolase (EC 4.1.3.16), which catalyzes the final step in the metabolic pathway of hydroxyproline, releasing glyoxylate and pyruvate. This gene is predominantly expressed in the liver and kidney, and mutations in this gene are found in patients with primary hyperoxalurea type III. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Nov 2010]

Canonical amino-acid sequenceUniProt

327 residues, UniProt reviewed canonical sequence.

>Q86XE5|HOGA1
     1  MLGPQVWSSV RQGLSRSLSR NVGVWASGEG KKVDIAGIYP PVTTPFTATA EVDYGKLEEN
    61  LHKLGTFPFR GFVVQGSNGE FPFLTSSERL EVVSRVRQAM PKNRLLLAGS GCESTQATVE
   121  MTVSMAQVGA DAAMVVTPCY YRGRMSSAAL IHHYTKVADL SPIPVVLYSV PANTGLDLPV
   181  DAVVTLSQHP NIVGMKDSGG DVTRIGLIVH KTRKQDFQVL AGSAGFLMAS YALGAVGGVC
   241  ALANVLGAQV CQLERLCCTG QWEDAQKLQH RLIEPNAAVT RRFGIPGLKK IMDWFGYYGG
   301  PCRAPLQELS PAEEEALRMD FTSNGWL

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against HOGA1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.27
Highest tissue expression
54 nTPM

Expression across tissuesHPA

Tissue

  • liver: 54 nTPM
  • kidney: 48 nTPM
  • heart muscle: 20 nTPM
  • choroid plexus: 16 nTPM
  • pancreas: 14 nTPM
  • tongue: 11 nTPM

Single-cell type

  • choroid plexus epithelial cells: 72 nCPM
  • ependymal cells: 39 nCPM
  • bergmann glia: 37 nCPM
  • astrocytes: 23 nCPM
  • oligodendrocytes: 15 nCPM
  • late spermatids: 15 nCPM

Immune cell

  • neutrophil: 0.8 nTPM
  • basophil: 0.5 nTPM
  • naive B-cell: 0.3 nTPM
  • plasmacytoid DC: 0.3 nTPM
  • classical monocyte: 0.2 nTPM
  • eosinophil: 0.2 nTPM

Brain region

  • choroid plexus: 24 nTPM
  • white matter: 22 nTPM
  • cerebellum: 20 nTPM
  • midbrain: 20 nTPM
  • medulla oblongata: 18 nTPM
  • pons: 18 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about HOGA1.

Disease | AllUniProt

Conditions HOGA1 is implicated in, by any mechanism.

Disease | GeneticClinVar

141 pathogenic / likely-pathogenic of 584 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.77
gnomAD pLI
0
gnomAD missense Z
-0.28
DepMap mean gene effect
-0.05
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads HOGA1 as an antibody target. Whether an autoantibody or antibody against HOGA1 could matter depends on whether native HOGA1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

HOGA1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label HOGA1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/HOGA1. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...